KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Non Operating Income (2016 - 2025)

Charles River Laboratories International has reported Non Operating Income over the past 17 years, most recently at $12.1 million for Q4 2025.

  • Quarterly results put Non Operating Income at $12.1 million for Q4 2025, up 153.29% from a year ago — trailing twelve months through Dec 2025 was -$22.6 million (down 36.66% YoY), and the annual figure for FY2025 was -$22.6 million, down 36.66%.
  • Non Operating Income for Q4 2025 was $12.1 million at Charles River Laboratories International, up from -$22.6 million in the prior quarter.
  • Over the last five years, Non Operating Income for CRL hit a ceiling of $115.5 million in Q4 2022 and a floor of -$39.8 million in Q2 2022.
  • Median Non Operating Income over the past 5 years was -$3.0 million (2023), compared with a mean of $2.6 million.
  • Biggest five-year swings in Non Operating Income: soared 5476.59% in 2022 and later crashed 972.61% in 2025.
  • Charles River Laboratories International's Non Operating Income stood at $2.1 million in 2021, then soared by 5476.59% to $115.5 million in 2022, then dropped by 6.76% to $107.7 million in 2023, then plummeted by 121.07% to -$22.7 million in 2024, then skyrocketed by 153.29% to $12.1 million in 2025.
  • The last three reported values for Non Operating Income were $12.1 million (Q4 2025), -$22.6 million (Q3 2025), and $154000.0 (Q2 2025) per Business Quant data.